MENU
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apellis Pharmaceuticals (APLS) Ownership - Who owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade... Show more
Industry: #Medical Distributors
Profile
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.08B
P/E Ratio
N/A
Total Cash
370.04M
Projected Growth
N/A
Total Debt
469.77M
Revenue
754.65M
Risk (Beta)
-0.48
Dividend Yield
N/A
Total Cash/Share
2.93
Total Debt/Equity
N/A
Revenue/Share
6.03 USD as % of share price
Fundamentals
APLS
Capitalization
3.08B
P/E Ratio
N/A
Risk (Beta)
-0.48
Dividend Yield
N/A
Total Cash
370M
Total Cash/Share
2.93
Total Debt
470M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.03%
Revenue
755M
ROE
N/A
Book Value
156M
P/B Ratio
19.69
Cash Flow
N/A
Earnings
-1.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
3.77
Current Revenue Per Employee
251400.00
Dividends Per Share - Security
N/A
EBITDA
-178.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.37
Revenue To Assets
-26.44
Shares Held By Institutions
5.45B
Shares Outstanding - Current
126M
Total Liabilities
665M
Total Volume MTD
N/A
Value
-1
Gain YTD
-23.629
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. APLS showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com